Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Cost-effectiveness of disease-modifying therapy for multiple sclerosis

7 references·2 citing·34 second hop

FromToDepth

this work references cited by second hop

References

1992The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.33,714 cited
1992The MOS 36-ltem Short-Form Health Survey (SF-36)30,026 cited
2004Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions945 cited
2003What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D.406 cited
2006Costs and quality of life in multiple sclerosis286 cited
2000Performance of the SF-36, SF-12, and RAND-36 Summary Scales in a Multiple Sclerosis Population176 cited
2003Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosisCommentary: Evaluating disease modifying treatments in multiple sclerosis142 cited

Cited by

2017Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA91 cited
2011What's fueling the biotech engine—2010 to 201179 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work